Speak to a Representative

If you would like an Aspire Pharma representative to contact you about Controcyst, please complete the form with your details.

Country(Required)

England

Northern Ireland

Scotland

Wales

Name(Required)

First Last

Email(Required)

Job title or speciality(Required)

Name of hospital, practice or clinic(Required)

Hospital, practice or clinic postcode(Required)

Registered council

Please select which council you are a member of from the options below. You will then be prompted to input your registration number.

GMC

NMC

GPhC

HCPC

Registration number

Please provide your registration number to aid with the verification of your form submission.

If you have been in contact with an Aspire Pharma Key Account Manager, please select who you have spoken with:

Stay in touch

Please tick this box if you would like to receive emails from Aspire Pharma Ltd about medicines, research initiatives, products and services, including details of webinars and events. Our privacy policy is available at https://aspirepharma.com/privacy-policy/. By ticking I understand that I can opt out at any time by emailing: [email protected].

I confirm that I am a registered UK healthcare professional and consent to receive both promotional and non-promotional information, including educational resources and medicine updates, from Aspire Pharma via email and post.

HCP confirmation(Required)

By ticking this box you confirm you are a UK Healthcare Professional, and that you accept Aspire Pharma Ltd’s Data Protection Policy and Terms and Conditions.

I am a UK Healthcare Professional

Always read the label.

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148.

MAT-UK-CON-0031-1 | June 2026

Home
Product Information

Contact
Speak to a Representative

MAT-UK-CON-0024-1 | June 2026

Link to Instagram
Link to Facebook

Terms & Conditions
Privacy Policy
Cookie Policy
Modern Slavery & Human Trafficking Policy

Scroll to top